These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37537250)

  • 21. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN; Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin.
    Ma XX; Wang EH; Liu Y; Luo EJ
    J Med Microbiol; 2011 Nov; 60(Pt 11):1661-1668. PubMed ID: 21799199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.
    Ahlstrand E; Svensson K; Persson L; Tidefelt U; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1349-54. PubMed ID: 21744039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
    Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycopeptide and daptomycin susceptibility trends among clinical isolates of methicillin-resistant Staphylococcus aureus in a tertiary care center in North India.
    Singh A; Prasad KN; Rai RP; Singh SK; Rahman M; Tripathi A; Srivastava JK
    J Infect Public Health; 2015; 8(4):341-5. PubMed ID: 25797814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
    Bannerman TL; Wadiak DL; Kloos WE
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D; Brown DF; Soussy CJ
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
    Khurana S; Mathur P; Malhotra R
    J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
    Rybak MJ; Cha R; Cheung CM; Meka VG; Kaatz GW
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):119-25. PubMed ID: 15698717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods.
    Jansen B; Schumacher-Perdreau F; Pulverer G
    Zentralbl Bakteriol; 1995 Oct; 282(4):402-8. PubMed ID: 9810663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiological profile of methicillin resistant Staphylococcus epidermidis with diminished sensitivity to teicoplanin and isolated from neutropenic patients at the National Center of Bone Marrow Transplantation in Tunis].
    Ben Hassen A; Gréco A; Jouaihia W; Leclercq R
    Pathol Biol (Paris); 2001 Oct; 49(8):634-40. PubMed ID: 11692751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro studies of the pharmacodynamics of teicoplanin against Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium.
    Odenholt I; Löwdin E; Cars O
    Clin Microbiol Infect; 2003 Sep; 9(9):930-7. PubMed ID: 14616681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G; Passot S; Lucht F; Dorche G
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.